Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common stock, par value $0.0001 per share
-
Shares outstanding
-
151,865,218
-
Total 13F shares
-
113,669,304
-
Share change
-
-355,534
-
Total reported value
-
$4,576,107,601
-
Put/Call ratio
-
69%
-
Price per share
-
$40.26
-
Number of holders
-
239
-
Value change
-
-$120,106,781
-
Number of buys
-
137
-
Number of sells
-
122
Institutional Holders of Adaptive Biotechnologies Corp - Common stock, par value $0.0001 per share (ADPT) as of Q1 2021
As of 31 Mar 2021,
Adaptive Biotechnologies Corp - Common stock, par value $0.0001 per share (ADPT) was held by
239 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
113,669,304 shares.
The largest 10 holders included
VIKING GLOBAL INVESTORS LP, Matrix Capital Management Company, LP, VANGUARD GROUP INC, PRICE T ROWE ASSOCIATES INC /MD/, BlackRock Inc., ARK Investment Management LLC, GILDER GAGNON HOWE & CO LLC, MASSACHUSETTS FINANCIAL SERVICES CO /MA/, Neuberger Berman Group LLC, and Capital International Investors.
This page lists
240
institutional shareholders reporting positions in this security
for the Q1 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.